Breaking News, Promotions & Moves

Telix Pharmaceuticals Reorganizes and Updates Leadership

Aims to optimize the development and commercialization of theranostic radiopharmaceuticals.

Author Image

By: Charlie Sternberg

Associate Editor

Telix Pharmaceuticals Limited, which recently agreed to acquire IsoTherapeutics Group, has announced new leadership appointments as part of an internal reorganization to align its operations across four business units.   The updated business model comprises Therapeutics, Precision Medicine (Diagnostics), Lightpoint (Medtech) and Telix Manufacturing Solutions (TMS).   Leadership appointments include:   Richard Valeix, Chief Executive Officer, Telix Therapeutics (formerly Group Chief ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters